| Product Name | NebuSelect™ Recombinant Biotinylated Cynomolgus CD24 , hFc-tag |
|---|---|
| Catalog Number | NBL-241787 |
| Alias/Synonyms | CD24; CD 24; CD24 molecule; CD24A; FLJ22950; FLJ43543; MGC75043 |
| Appearance | see COA |
| Molecule Weight | Thr27-Lys54 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | I7GKK1-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241787-100ug | 100ug | Inquire | Inquire | |
| NBL-241787-1mg | 1mg | Inquire | Inquire | |
| NBL-241787-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Cynomolgus CD24 , hFc-tag
Catalog#:
NBL-241787
Description:
NebuSelect™ Recombinant Biotinylated Cynomolgus CD24 , hFc-tag(Cat#NBL-241787) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Thr27-Lys54.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 30.2 kDa. Due to glycosylation, the protein migrates to 50-58 kDa based on Bis-Tris PAGE result.
Target Name:
CD24; CD 24; CD24 molecule; CD24A; FLJ22950; FLJ43543; MGC75043
Target Information:
CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers.
Amino Acid Sequence:
Thr27-Lys54
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.